Alzyn, LLC and Young Living Essential Oils, LLC to Co-Develop an All-Natural Oral Delivery Form for Brain Health

Share Article

Alzyn LLC, a Georgia based innovative nutrigenomics consumer health and wellness company focused on brain health protection, announced today that it has executed a letter of intent (LOI) with Young Living Essential Oils, the world leader in essential oils, for the joint development of an oral delivery form based on Alzyn’s patented formulation. Upon successful development, Young Living will have exclusive marketing rights in its designated market channel.

Dr. Michael Buch, Chief Science Officer at Young Living commented “We look forward to working with Alzyn to help meet one of the great consumer health concerns of 21st century.”

Alzyn LLC, a Georgia based innovative nutrigenomics consumer health and wellness company focused on brain health protection, announced today that it has executed a letter of intent (LOI) with Young Living Essential Oils, the world leader in essential oils, for the joint development of an oral delivery form based on Alzyn’s patented formulation. Upon successful development, Young Living will have exclusive marketing rights in its designated market channel.

Alzyn’s patented formulation was licensed from the Florida State University Research Foundation, Inc. and was discovered by Dr. Ewa Bienkiewicz, Research Associate Professor of Biomedical Sciences at Florida State University College of Medicine and Associate Editor of The Journal of Alzheimer’s Disease. Her research proved that the specific combination of Vitamin B12, Resveratrol, EGCG, and Melatonin has demonstrated the ability to reduce risks or maintain defenses from changes associated with the aging brain, better than each of the four products if taken individually or in any other combination.

“We are delighted to have Young Living as a partner. Our combined efforts will go a long way in providing much-needed supplements of the highest quality and supporting the health of the consumers we serve,” said Chris Efessiou, Alzyn LLC Chairman and CEO.
Dr. Michael Buch, Chief Science Officer at Young Living commented “We look forward to working with Alzyn to help meet one of the great consumer health concerns of 21st century.”

About Alzyn
Alzyn, LLC. is an innovative nutrigenomics consumer health and wellness company with a novel proprietary technology that uniquely enables the delivery of key nutrients that have been shown to protect brain cell health. Healthy brain cells are known to defend against diminished mental capacity. The company has a transdermal product on the market which coupled four Generally Regarded As Safe (GRAS) ingredients that have demonstrated favorable and statistically significant changes on several factors (including tau and beta amyloids) impacting disease or age-related cognitive loss with a unique delivery system that can carry these ingredients across the blood-brain barrier. Several other products are under development. The company is advised by Newport, LLC.

About Young Living Essential Oils
Young Living Essential Oils, LLC, based in Lehi, Utah, is the world leader in essential oils, offering the highest quality oil-infused products available. Young Living takes its industry leadership seriously, setting the standard with its proprietary Seed to Seal® quality commitment, which involves three critical pillars: Sourcing, Science, and Standards. Young Living's products—which all come from corporate-owned farms, partner farms, and Seed to Seal-certified suppliers—not only support a healthy lifestyle but also provide opportunities for over five million global members to find a sense of purpose and whole-life wellness by aligning their work with their values and passions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Efessiou
Visit website